Abstract Angelman syndrome is a severe neurodevelopmental disorder caused by the loss of UBE3A, a gene that encodes an E3 ubiquitin ligase1,2. The mechanisms that underlie Angelman syndrome are not well understood, and in particular, the link between UBE3A substrates and disease phenotypes remains uncertain3. Here, using gain- and loss-of-function mutations in UBE3A4,5 along with unbiased proteomics, we show that asparagine synthetase (ASNS) is a target of UBE3A.
Kevin Cho
As seen in:
Medium,
Nature,
Wiley Online Library,
El Economista (Spain),
ACS Publications,
Science Magazine,
BioRxiv,
Cell Metabolism,
Cell Reports,
EIN News
and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Kevin
Contact Kevin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack